Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd. (600389.SS)
Nantong, CN
Nantong Jiangshan Agrochemical & Chemicals Co.,Ltd., headquartered in Nantong, China, specializes in the production and distribution of a broad spectrum of chemical products. Its core business activities encompass agrochemicals, various resins, chlorine-caustic soda, and fine chemicals. The company's comprehensive agrochemical portfolio features numerous herbicides, such as glyphosate, alachlor, acetochlor, butachlor, and metolachlor; insecticides, including dichlorvos, trichlorphon, nitenpyram, and imidaclothiz; and fungicides like prochloraz and its manganese complex derivative. Furthermore, Nantong Jiangshan manufactures essential intermediate products, including chloral, phosphorus acid, trimethyl and dimethyl phosphite, phosphorus trichloride, PMIDA, paraformaldehyde, and chlormethane. Its offerings also extend to specialized materials, specifically microporous insulating boards, nanometer aluminum oxide, and flame retardant solutions. With a significant international presence, the company's products are supplied to over 40 countries and regions across Asia, Europe, the United States, and Africa.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.81% | -4.36% | -15.05% | -18.92% | +14.56% | -2.89% | +28.13% | +15.91% | -0.97% | +153.09% | +343.94% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+7.0% ★ Q1'26: +11.4% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+138.5% ★ Q1'26: +16.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-0.2% Q1'26: -14.2% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+8.1% ★ Q1'26: +9.4% (vs Q1'25)
-
ROIC Chemicals: +3.4%+6.9% ★ Q1'26: +9.0% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-0.2% ★ Q1'26: -0.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×4.26× Q1'26: 4.64× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.68B
est: 5.36B (-50.1%)
|
3.64B
est: 3.32B (+9.8%)
|
3.92B
est: 3.29B (+19.3%)
|
4.78B
est: 3.35B (+42.7%)
|
5.12B
est: 5.49B (-6.8%)
|
6.48B
est: 6.44B (+0.7%)
|
8.35B
est: 9.59B (-13.0%)
|
5.09B
est: 4.93B (+3.2%)
|
5.43B
est: 5.55B (-2.1%)
|
5.81B
est: 6.46B (-10.0%)
|
7.07B
7.04B – 7.11B
+9.5% YoY
|
8.04B
7.83B – 8.24B
+13.6% YoY
|
8.51B
8.25B – 8.77B
+5.9% YoY
|
| EBITDA |
294.34M
est: 806.66M (-63.5%)
|
602.52M
est: 498.86M (+20.8%)
|
663.25M
est: 494.35M (+34.2%)
|
529.31M
est: 503.98M (+5.0%)
|
598.26M
est: 826.52M (-27.6%)
|
1.19B
est: 968.24M (+22.7%)
|
2.31B
est: 1.44B (+60.3%)
|
486.95M
est: 741.55M (-34.3%)
|
431.02M
est: 842.00M (-48.8%)
|
716.61M
est: 980.08M (-26.9%)
|
1.07B
1.07B – 1.08B
+9.5% YoY
|
1.22B
1.19B – 1.25B
+13.6% YoY
|
1.29B
1.25B – 1.33B
+5.9% YoY
|
| EBIT |
37.71M
est: 604.04M (-93.8%)
|
346.14M
est: 373.56M (-7.3%)
|
421.61M
est: 370.18M (+13.9%)
|
333.70M
est: 377.39M (-11.6%)
|
396.77M
est: 618.91M (-35.9%)
|
968.28M
est: 725.03M (+33.5%)
|
2.07B
est: 1.08B (+91.9%)
|
248.55M
est: 555.29M (-55.2%)
|
212.72M
est: 629.42M (-66.2%)
|
472.84M
est: 732.65M (-35.5%)
|
802.40M
798.40M – 806.41M
+9.5% YoY
|
911.55M
888.40M – 934.71M
+13.6% YoY
|
965.37M
935.63M – 995.10M
+5.9% YoY
|
| Net Income |
10.57M
est: 373.01M (-97.2%)
|
248.99M
est: 261.90M (-4.9%)
|
392.10M
est: 282.73M (+38.7%)
|
300.06M
est: 291.66M (+2.9%)
|
334.93M
est: 419.63M (-20.2%)
|
816.45M
est: 845.22M (-3.4%)
|
1.84B
est: 1.91B (-3.5%)
|
282.95M
est: 336.60M (-15.9%)
|
224.40M
est: 271.31M (-17.3%)
|
532.60M
est: 589.99M (-9.7%)
|
785.94M
777.62M – 794.25M
+33.2% YoY
|
933.43M
927.31M – 939.56M
+18.8% YoY
|
1.07B
1.05B – 1.09B
+14.4% YoY
|
| SGA |
163.12M
est: 221.00M (-26.2%)
|
167.62M
est: 136.67M (+22.6%)
|
167.15M
est: 135.44M (+23.4%)
|
181.93M
est: 138.07M (+31.8%)
|
152.07M
est: 226.44M (-32.8%)
|
213.05M
est: 265.27M (-19.7%)
|
270.56M
est: 395.38M (-31.6%)
|
273.08M
est: 203.16M (+34.4%)
|
311.91M
est: 252.22M (+23.7%)
|
295.68M
est: 293.58M (+0.7%)
|
321.53M
319.93M – 323.14M
+9.5% YoY
|
365.27M
355.99M – 374.55M
+13.6% YoY
|
386.83M
374.92M – 398.75M
+5.9% YoY
|
| EPS |
0.02
est: 0.86 (-97.2%)
|
0.58
est: 0.61 (-4.4%)
|
0.91
est: 0.66 (+38.9%)
|
0.70
est: 0.68 (+3.6%)
|
0.78
est: 0.97 (-19.8%)
|
1.90
est: 1.96 (-3.0%)
|
4.22
est: 4.43 (-4.7%)
|
0.65
est: 0.78 (-16.7%)
|
0.52
est: 0.63 (-17.5%)
|
1.24
est: 1.37 (-9.5%)
|
1.83
1.81 – 1.84
+33.2% YoY
|
2.17
2.15 – 2.18
+18.8% YoY
|
2.48
2.43 – 2.53
+14.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-28 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-27 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-26 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-25 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-22 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-21 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-20 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-19 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-18 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-15 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-14 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-13 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-12 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-11 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-08 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-07 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-06 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-30 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-29 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 60.2K | 0.46% |
| 2 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 387.8K | 0.06% |
| 3 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 183.6K | 0.39% |
| 4 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 11.8K | 0.48% |
| 5 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 26.6K | 0.26% |
| 6 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 1.31M | 0.06% |
| 7 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 60.9K | 0.29% |
| 8 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 71.1K | 0.28% |
| 9 | Vanguard ESG International Stock ETF VSGX | 0.00% | 31.8K | 0.10% |
| 10 | Vanguard Total International Stock ETF VXUS | 0.00% | 1.47M | 0.05% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chang Chun Meng | Director & Executive Deputy GM | — | male |
| Hai Huang | Financial Director & Manager and Accounting Supervisor | — | male |
| Hui Du | Chief Research & Development Officer | — | male |
| Jin Hua Song | Deputy GM, Secretary & Financial Manager | — | male |
| Li Wang | GM & Director | — | male |
| Wei Ji | Deputy General Manager | — | male |
| Xu Wang | Deputy General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 600389.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
